Search This Blog

Wednesday, April 19, 2017

Amgen Launches Neulasta® (pegfilgrastim) Onpro® NARRATIVES

THOUSAND OAKS, Calif.April 18, 2017 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of Neulasta® (pegfilgrastim) Onpro®NARRATIVES, an online media resource about the value of a cancer care team that provides comprehensive support for patients receiving strong chemotherapy. Intended to support conversations between cancer patients undergoing strong chemotherapy and their healthcare team about potential risk for infection due to a low white blood cell count, Neulasta Onpro NARRATIVES shares personal cancer stories as well as educational materials.



Amgen - Investors - RSS Content

No comments:

Post a Comment